- Home
- HQI vs BDTX Comparison
HQI vs BDTX Comparison
Compare HQI & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HQI | BDTX |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United States |
| Employees | 65000 | N/A |
| Industry | Professional Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.0M | 116.8M |
| IPO Year | 2008 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HQI | BDTX |
|---|---|---|
| Price | $10.86 | $2.12 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $13.00 | $10.40 |
| AVG Volume (30 Days) | 11.1K | ★ 564.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | N/A | ★ 32.45 |
| EPS | 0.34 | ★ 0.65 |
| Revenue | ★ $34,598,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $31.88 | ★ $3.28 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.38 | $1.20 |
| 52 Week High | $13.78 | $4.94 |
Technical Indicators
Market Signals| Indicator | HQI | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.32 | 40.78 |
| Support Level | $10.38 | $1.93 |
| Resistance Level | $11.99 | $2.67 |
| Average True Range (ATR) | 0.70 | 0.14 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 27.60 | 26.76 |
Price Performance
Historical ComparisonAbout HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.